1.Putignani, L, Menichella, D. Global distribution, public health and clinical impact of the protozoan pathogen cryptosporidium. Interdisciplinary Perspectives on Infectious Diseases Published online: 14 July 2010. doi:10.1155/2010/753512.
2.Feng, Y, Xiao, L. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clinical Microbiology Review 2011; 24: 110–140.
3.Kuchenmüller, T, et al. Estimating the global burden of foodborne diseases – a collaborative effort. Eurosurveillance 2009; 41: 191–195.
4.Batz, M, et al. Priority setting for foodborne and zoonotic pathogens. Bilthoven, The Netherlands, 2007. Med-Vet-Net; Med-Vet-Net Report no. 07-001, 53 pp.
5.Vijgen, SMC, et al. Disease burden and related costs of cryptosporidiosis and giardiasis in the Netherlands. Bilthoven, the Netherlands: National Institute for Public Health and the Environment (RIVM), 2007, 58 pp.
6.Scallan, E, et al. Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases 2011; 17: 7–15.
8.Taylor, M, et al. The impact of international travel on the epidemiology of enteric infections, British Columbia, 2008. Canadian Journal of Public Health 2010; 101: 332–336.
9.Ravel, A, et al. Description and burden of travel-related cases caused by enteropathogens reported in a Canadian community. Journal Travel Medicine 2011; 18: 8–19.
10.Pintar, KD, et al. A modified case-control study of cryptosporidiosis (using non-Cryptosporidium-infected enteric cases as controls) in a community setting. Epidemiology and Infection 2009; 137: 1789–1799.
11.Odoi, A, et al. Determinants of the geographical distribution of endemic giardiasis in Ontario, Canada: a spatial modelling approach. Epidemiolology and Infection 2004; 132: 967–976.
12.Greig, JD, et al. A descriptive analysis of giardiasis cases reported in Ontario, 1990–1998. Canadian Journal of Public Health 2001; 92: 361–365.
13.Kwong, JC, et al. Ontario Burden of Infectious Disease Study (ONBOIDS). Toronto, ON, Canada: Ontario Agency for Health Protection and Promotion, Institute for Clinical Evaluative Sciences, 2010, 198 pp.
14.Health Canada. Enteric protozoa: Giardia and Cryptosporidium – document for public comment. Ottawa, ON, Canada: Health Canada, 2010, 89 pp.
16.Rothman, KJ, Greenland, S. Modern Epidemiology, 2nd edn.Philadelphia, PA, USA: Lippincott Williams & Wilkins, 1998, 738 pp.
18.Region of Waterloo Public Health. Waterloo Region status report enteric disease 2005–2009. Waterloo, ON, Canada, 2010; 53 pp.
19.Laupland, KB, Church, DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infectious Diseases 2005; 5: 72.
20.Keegan, VA, et al. Epidemiology of enteric disease in C-EnterNet's pilot site – Waterloo region, Ontario, 1990 to 2004. Canadian Journal of Infectious Diseases & Medical Microbiology 2009; 20: 79–87.
21.Majowicz, SE, et al. Descriptive analysis of endemic cryptosporidiosis cases reported in Ontario, 1996–1997. Canadian Journal of Public Health 2001; 92: 62–66.
22.Snel, SJ, et al. A tale of two parasites: the comparative epidemiology of cryptosporidiosis and giardiasis. Epidemiology and Infection 2009; 137: 1641–1650.
23.Espelage, W, et al. Characteristics and risk factors for symptomatic Giardia lamblia infections in Germany. BMC Public Health 2010; 10: 41.
29.Hunt, RH, et al. Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study. Canadian Journal of Gastroenterology 2007; 21: 31–37.
30.Sandler, RS, et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Digestive Disases and Sciences 2000; 45: 1166–1171.
31.Humphries, A, et al. Symptoms and signs of lower gastrointestinal disease. Medicine 2007; 35: 136–141.
32.Chang, L, et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1435–1446.
33.Odoi, A, et al. Geographical and temporal distribution of human giardiasis in Ontario, Canada. International Journal of Health Geographics 2003; 2: 5.
34.Thompson, RC, Palmer, CS and O'Handley, R. The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Veterinary Journal 2008; 177: 18–25.
35.Gagnon, F, et al. Risk of giardiasis associated with water supply in an endemic context. International Journal of Environmental Health Research 2006; 16: 349–359.
36.Ramirez, NE, Ward, LA, Sreevatsan, S. A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes and Infection 2004; 6: 773–785.
37.Chalmers, RM, et al. Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales, 2004-2006. Epidemiology and Infection 2010; 139: 700–712.
38.Hunter, PR, et al. Sporadic cryptosporidiosis case-control study with genotyping. Emerging Infectious Diseases 2004; 10: 1241–1249.
39.Gonin, P, Trudel, L. Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR and enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 2003; 41: 237–241.